Todd Henderson - Optimi Health Head Cultivation
| OPTHF Stock | USD 0.16 0.01 5.88% |
Insider
Todd Henderson is Head Cultivation of Optimi Health Corp
| Phone | 778 930 1321 |
| Web | https://www.optimihealth.ca |
Optimi Health Management Efficiency
The company has return on total asset (ROA) of (0.215) % which means that it has lost $0.215 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3964) %, meaning that it generated substantial loss on money invested by shareholders. Optimi Health's management efficiency ratios could be used to measure how well Optimi Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Moshe Mizrahy | InMode | 71 | |
| Blake Borgeson | Recursion Pharmaceuticals | 42 | |
| Claudio Ramolo | Rumble Inc | 36 | |
| MBA JD | Recursion Pharmaceuticals | 66 | |
| Benjamin MS | Recursion Pharmaceuticals | 41 | |
| Donna Dea | Aerovate Therapeutics | N/A | |
| Nava TalLauner | InMode | ||
| Wender Vinhadelli | Brasilagro Adr | N/A | |
| Timothy Pigot | Aerovate Therapeutics | 53 | |
| Shafique MD | Recursion Pharmaceuticals | 53 | |
| Michael Secora | Recursion Pharmaceuticals | 41 | |
| Benjamin Dake | Aerovate Therapeutics | 48 | |
| Jared Allenbach | Recursion Pharmaceuticals | N/A | |
| Timothy MBA | Aerovate Therapeutics | 62 | |
| Hunter MD | Aerovate Therapeutics | 58 | |
| Spero MD | InMode | 52 | |
| Michael Kreindel | InMode | 56 | |
| George Eldridge | Aerovate Therapeutics | 61 | |
| Christopher Pavlovski | Rumble Inc | 40 | |
| Yair Malca | InMode | 46 | |
| Elisa Castelani | Brasilagro Adr | N/A | |
Management Performance
| Return On Equity | -0.4 | |||
| Return On Asset | -0.21 |
Optimi Health Corp Leadership Team
Elected by the shareholders, the Optimi Health's board of directors comprises two types of representatives: Optimi Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Optimi. The board's role is to monitor Optimi Health's management team and ensure that shareholders' interests are well served. Optimi Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Optimi Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ann Little, HR Mang | ||
| Bryan Safarik, COO CoFounder | ||
| Justin Kirkland, Chief Board | ||
| John Wilson, CoFounder Chairman | ||
| William Ciprick, Chief Officer | ||
| Dane Stevens, Chief CoFounder | ||
| Todd Henderson, Head Cultivation | ||
| Laura Chow, Director Sales | ||
| Jacob Safarik, CFO CoFounder | ||
| Leah Hodges, Co Sec |
Optimi Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Optimi Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.4 | |||
| Return On Asset | -0.21 | |||
| Operating Margin | (85.83) % | |||
| Current Valuation | 12.3 M | |||
| Shares Outstanding | 86.77 M | |||
| Shares Owned By Insiders | 16.72 % | |||
| Shares Owned By Institutions | 0.05 % | |||
| Price To Book | 1.22 X | |||
| Price To Sales | 379.65 X | |||
| Revenue | 80.72 K |
Currently Active Assets on Macroaxis
Other Information on Investing in Optimi OTC Stock
Optimi Health financial ratios help investors to determine whether Optimi OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Optimi with respect to the benefits of owning Optimi Health security.